{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:32:41Z","timestamp":1784287961317,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005294","name":"MASSACHUSETTS GENERAL HOSPITAL","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006098","name":"Radiological Society of North America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.clinimag.2021.11.018","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T21:38:42Z","timestamp":1637357922000},"page":"179-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Contralateral breast cancer after curative-intent treatment for ductal carcinoma in situ: Rate and associated clinicopathological and imaging risk factors"],"prefix":"10.1016","volume":"82","author":[{"given":"Keegan","family":"Hovis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mercaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geunwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie R.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawakalitu O.","family":"Oseni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinimag.2021.11.018_bb0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.1991.03460030097037","article-title":"Treatment of early-stage breast cancer","volume":"265","author":"NIH Consensus Conference","year":"1991","journal-title":"JAMA"},{"issue":"33","key":"10.1016\/j.clinimag.2021.11.018_bb0010","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","article-title":"Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment","volume":"25","author":"Tuttle","year":"2007","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.clinimag.2021.11.018_bb0015","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1200\/JCO.2008.20.1681","article-title":"Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ","volume":"27","author":"Tuttle","year":"2009","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clinimag.2021.11.018_bb0020","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1245\/s10434-010-1091-3","article-title":"Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998\u20132007","volume":"17","author":"Yao","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.clinimag.2021.11.018_bb0025","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1245\/s10434-019-07628-w","article-title":"Trends in unilateral and contralateral prophylactic mastectomy use in ductal carcinoma in situ of the breast: patterns and predictors","volume":"26","author":"Zhang","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.clinimag.2021.11.018_bb0030","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.clinimag.2021.11.018_bb0035","doi-asserted-by":"crossref","first-page":"djv263","DOI":"10.1093\/jnci\/djv263","article-title":"Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ","volume":"107","author":"Worni","year":"2015","journal-title":"J Natl Cancer Inst."},{"issue":"5","key":"10.1016\/j.clinimag.2021.11.018_bb0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.amjsurg.2011.01.018","article-title":"Increasing incidence of bilateral mastectomies: the patient perspective","volume":"201","author":"Han","year":"2011","journal-title":"Am J Surg"},{"issue":"10","key":"10.1016\/j.clinimag.2021.11.018_bb0045","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1245\/s10434-012-2525-x","article-title":"Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age","volume":"19","author":"Fisher","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.clinimag.2021.11.018_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.7326\/0003-4819-159-6-201309170-00003","article-title":"Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey","volume":"159","author":"Rosenberg","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinimag.2021.11.018_bb0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.breast.2016.04.005","article-title":"Contralateral prophylactic mastectomy (CPM): a systematic review of patient reported factors and psychological predictors influencing choice and satisfaction","volume":"28","author":"Ager","year":"2016","journal-title":"Breast"},{"issue":"9169","key":"10.1016\/j.clinimag.2021.11.018_bb0060","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clinimag.2021.11.018_bb0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0960-9776(03)00152-8","article-title":"The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry","volume":"12","author":"Claus","year":"2003","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.clinimag.2021.11.018_bb0070","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0360-3016(03)00203-7","article-title":"Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study","volume":"56","author":"Gao","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clinimag.2021.11.018_bb0075","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1309\/WH9LA543NR76Y29J","article-title":"Pathologic variables predictive of breast events in patients with ductal carcinoma in situ","volume":"128","author":"Fisher","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.11.018_bb0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10549-007-9807-1","article-title":"Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast","volume":"111","author":"Innos","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.clinimag.2021.11.018_bb0085","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/cncr.21864","article-title":"Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988\u20132001","volume":"106","author":"Li","year":"2006","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.clinimag.2021.11.018_bb0090","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1245\/s10434-017-5931-2","article-title":"Contralateral breast cancer risk in women with ductal carcinoma in situ: is it high enough to justify bilateral mastectomy?","volume":"24","author":"Miller","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.11.018_bb0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jbi\/wbz039","article-title":"Ductal carcinoma in situ: current concepts in biology, imaging, and treatment","volume":"1","author":"Shehata","year":"2019","journal-title":"J Breast Imaging"},{"issue":"3","key":"10.1016\/j.clinimag.2021.11.018_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.clinimag.2021.11.018_bb0105","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1245\/s10434-020-08576-6","article-title":"Do eligibility criteria for ductal carcinoma in situ (DCIS) active surveillance trials identify patients at low risk for upgrade to invasive carcinoma?","volume":"27","author":"Oseni","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.clinimag.2021.11.018_bb0110","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1007\/s00330-020-07021-2","article-title":"Ductal carcinoma in situ on digital mammography versus digital breast tomosynthesis: rates and predictors of pathologic upgrade","volume":"30","author":"Kim","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clinimag.2021.11.018_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109130","article-title":"Pre-operative MRI in patients with ductal carcinoma in situ: is MRI useful for identifying additional disease?","volume":"129","author":"Lamb","year":"2020","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.11.018_bb0120","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1245\/s10434-020-09101-5","article-title":"Predictors of reexcision following breast-conserving surgery for ductal carcinoma in situ","volume":"28","author":"Lamb","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.11.018_bb0125","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.acra.2020.02.011","article-title":"Noncalcified ductal carcinoma in situ (DCIS): rate and predictors of upgrade to invasive carcinoma","volume":"28","author":"Lamb","year":"2021","journal-title":"Acad Radiol"},{"key":"10.1016\/j.clinimag.2021.11.018_bb0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clinimag.2020.11.050","article-title":"Symptomatic ductal carcinoma in situ (DCIS): upstaging risk and predictors","volume":"73","author":"Venkatesh","year":"2021","journal-title":"Clin Imaging"},{"issue":"10","key":"10.1016\/j.clinimag.2021.11.018_bb0135","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.acra.2019.09.025","article-title":"Ductal carcinoma in situ (DCIS) at breast MRI: predictors of upgrade to invasive carcinoma","volume":"27","author":"Lamb","year":"2020","journal-title":"Acad Radiol"},{"key":"10.1016\/j.clinimag.2021.11.018_bb0145","series-title":"ACR BI-RADS Atlas, Breast Imaging Reporting and Data System","article-title":"ACR BI-RADS mammography","author":"Sickles","year":"2013"},{"issue":"1","key":"10.1016\/j.clinimag.2021.11.018_bb0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1524-4741.2007.00521.x","article-title":"Positive, negative, and disparate\u2013women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy","volume":"14","author":"Altschuler","year":"2008","journal-title":"Breast J"},{"issue":"11","key":"10.1016\/j.clinimag.2021.11.018_bb0155","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1245\/s10434-011-1917-7","article-title":"Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits","volume":"18","author":"Frost","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.clinimag.2021.11.018_bb0160","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1245\/s10434-013-3108-1","article-title":"Operative risks associated with contralateral prophylactic mastectomy: a single institution experience","volume":"20","author":"Miller","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clinimag.2021.11.018_bb0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.clinimag.2021.11.018_bb0170","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.2010.34.0141","article-title":"Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24","volume":"30","author":"Allred","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clinimag.2021.11.018_bb0175","doi-asserted-by":"crossref","first-page":"452","DOI":"10.6004\/jnccn.2020.0016","article-title":"Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Gradishar","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"10.1016\/j.clinimag.2021.11.018_bb0180","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1245\/s10434-015-4668-z","article-title":"Adjuvant endocrine therapy in patients with ductal carcinoma in situ: a population-based retrospective analysis from 2005 to 2012 in the National Cancer Data Base","volume":"22","author":"Flanagan","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.clinimag.2021.11.018_bb0185","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1245\/s10434-017-5930-3","article-title":"Factors influencing use of hormone therapy for ductal carcinoma in situ: a National Cancer Database study","volume":"24","author":"Nguyen","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.11.018_bb0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.soc.2014.03.011","article-title":"Epidemiology of breast cancer","volume":"23","author":"Ban","year":"2014","journal-title":"Surg Oncol Clin N Am"},{"issue":"3","key":"10.1016\/j.clinimag.2021.11.018_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","article-title":"Risk factors for breast cancer in women with proliferative breast disease","volume":"312","author":"Dupont","year":"1985","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.clinimag.2021.11.018_bb0200","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1200\/JCO.2006.09.0217","article-title":"Stratification of breast cancer risk in women with atypia: a Mayo cohort study","volume":"25","author":"Degnim","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clinimag.2021.11.018_bb0205","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast\u2013risk assessment and management options","volume":"372","author":"Hartmann","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clinimag.2021.11.018_bb0210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13058-018-0967-1","article-title":"Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape","volume":"20","author":"Kader","year":"2018","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.clinimag.2021.11.018_bb0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/cncr.21571","article-title":"Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy","volume":"106","author":"Adepoju","year":"2006","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/j.clinimag.2021.11.018_bb0220","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1245\/s10434-019-07796-9","article-title":"Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis","volume":"26","author":"Miller","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clinimag.2021.11.018_bb0230","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"3 Pt A","key":"10.1016\/j.clinimag.2021.11.018_bb0235","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacr.2017.11.034","article-title":"Breast cancer screening in women at higher-than-average risk: recommendations from the ACR","volume":"15","author":"Monticciolo","year":"2018","journal-title":"J Am Coll Radiol"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707121004484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707121004484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:49:02Z","timestamp":1760269742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707121004484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":45,"alternative-id":["S0899707121004484"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2021.11.018","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contralateral breast cancer after curative-intent treatment for ductal carcinoma in situ: Rate and associated clinicopathological and imaging risk factors","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2021.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}